VC firms sell Biosensia
A consortium of VC firms has sold Dublin-based Biosensia to US-based Kypha.
The vendors include Act Venture Capital, Atlantic Bridge, Street Capital and Seroba Life Sciences.
To date, the group has raised roughly $10m.
Kypha is a US-based medical diagnostics company developing specialised biomarker testing solutions for precision monitoring of immune status and inflammation. The acquisition will strengthen Kypha's product commercialisation.
Company
Biosensia is based in Dublin, Ireland, and was founded by Gabriel Crean and Gareth Redmond in 2009. The company is a diagnostics platform and contract development company. Biosensia's RapiPlex is a proprietary diagnostic system designed to support CLIA-waived protocols and is capable of producing laboratory-quality quantitative and qualitative results with a disposable cartridge for up to 24 analytes in a multiplex format.
More on UK / Ireland
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater